Travel Vaccines Market Size, Share, and Outlook, H2-2025 Report- By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines) and Companies, 2021-2032
Description
Travel Vaccines Market Outlook
The global Travel Vaccines Market Size is valued at $5.8 Billion in 2025 and is forecast to reach $10.3 Billion in 2032 at a CAGR of 8.6%.
The Travel Vaccines Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Travel Vaccines Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Travel Vaccines Market Insights, 2025
The travel vaccines market in 2025 continues to grow in response to increasing international travel and heightened awareness of infectious disease prevention. Emerging viral outbreaks and re-emerging diseases have intensified demand for vaccines targeting pathogens such as yellow fever, typhoid, and Japanese encephalitis. Recent developments focus on improving vaccine efficacy through novel adjuvants and delivery technologies like needle-free injectors and thermostable formulations, enhancing accessibility in resource-limited regions. Digital health tools are being integrated to provide travelers with vaccine reminders and health information tailored to destinations. Global initiatives aimed at expanding immunization coverage among travelers are expanding. Regulatory agencies are streamlining approval pathways for travel vaccines to address urgent public health needs. The market also benefits from growing partnerships between governments, NGOs, and private companies to enhance vaccine availability and awareness. Safety monitoring systems have been strengthened, ensuring rapid response to adverse events.
Five Trends Shaping the Global Travel Vaccines Market in 2025 and Beyond
The global Travel Vaccines Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Travel Vaccines Industry?
The Travel Vaccines Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Travel Vaccines Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Travel Vaccines Market Segment Insights
The Travel Vaccines Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Travel Vaccines Industry Value Chain
The chapter identifies potential companies and their operations across the global Travel Vaccines Industry ecosystem. It assists decision-makers in evaluating global Travel Vaccines Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Travel Vaccines Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Travel Vaccines Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Travel Vaccines Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Travel Vaccines Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Travel Vaccines Market.
Europe Travel Vaccines Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Travel Vaccines Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Travel Vaccines Industry competitiveness. The report analyses the key Travel Vaccines Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Travel Vaccines Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Travel Vaccines Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Travel Vaccines Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Travel Vaccines Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Travel Vaccines Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Travel Vaccines Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Altimmune Inc, AstraZeneca Plc, Bavarian Nordic AS, CSL Ltd, Dynavax Technologies Corp, Emergent BioSolutions Inc, GlaxoSmithKline Plc, KM Biologics Co. Ltd, LG Chem Ltd, Merck and Co. Inc, Novartis AG, Pfizer Inc, Sanofi SA, Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, SK Chemicals Co. Ltd, Takeda Pharmaceutical Co. Ltd, Valneva SE. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Travel Vaccines Market Scope
Leading Segments
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
Leading Companies
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Travel Vaccines Market Size is valued at $5.8 Billion in 2025 and is forecast to reach $10.3 Billion in 2032 at a CAGR of 8.6%.
The Travel Vaccines Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Travel Vaccines Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Travel Vaccines Market Insights, 2025
The travel vaccines market in 2025 continues to grow in response to increasing international travel and heightened awareness of infectious disease prevention. Emerging viral outbreaks and re-emerging diseases have intensified demand for vaccines targeting pathogens such as yellow fever, typhoid, and Japanese encephalitis. Recent developments focus on improving vaccine efficacy through novel adjuvants and delivery technologies like needle-free injectors and thermostable formulations, enhancing accessibility in resource-limited regions. Digital health tools are being integrated to provide travelers with vaccine reminders and health information tailored to destinations. Global initiatives aimed at expanding immunization coverage among travelers are expanding. Regulatory agencies are streamlining approval pathways for travel vaccines to address urgent public health needs. The market also benefits from growing partnerships between governments, NGOs, and private companies to enhance vaccine availability and awareness. Safety monitoring systems have been strengthened, ensuring rapid response to adverse events.
Five Trends Shaping the Global Travel Vaccines Market in 2025 and Beyond
The global Travel Vaccines Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Travel Vaccines Industry?
The Travel Vaccines Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Travel Vaccines Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Travel Vaccines Market Segment Insights
The Travel Vaccines Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Travel Vaccines Industry Value Chain
The chapter identifies potential companies and their operations across the global Travel Vaccines Industry ecosystem. It assists decision-makers in evaluating global Travel Vaccines Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Travel Vaccines Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Travel Vaccines Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Travel Vaccines Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Travel Vaccines Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Travel Vaccines Market.
Europe Travel Vaccines Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Travel Vaccines Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Travel Vaccines Industry competitiveness. The report analyses the key Travel Vaccines Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Travel Vaccines Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Travel Vaccines Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Travel Vaccines Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Travel Vaccines Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Travel Vaccines Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Travel Vaccines Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Altimmune Inc, AstraZeneca Plc, Bavarian Nordic AS, CSL Ltd, Dynavax Technologies Corp, Emergent BioSolutions Inc, GlaxoSmithKline Plc, KM Biologics Co. Ltd, LG Chem Ltd, Merck and Co. Inc, Novartis AG, Pfizer Inc, Sanofi SA, Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, SK Chemicals Co. Ltd, Takeda Pharmaceutical Co. Ltd, Valneva SE. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Travel Vaccines Market Scope
Leading Segments
By Disease
Influenza
Diptheria
Hepatitis
Typhoid
Others
By End-User
Adult vaccines
Pediatric vaccines
Leading Companies
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
191 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Travel Vaccines Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Travel Vaccines Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Travel Vaccines Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Travel Vaccines Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Travel Vaccines Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Disease
- Influenza
- Diptheria
- Hepatitis
- Typhoid
- Others
- By End-User
- Adult vaccines
- Pediatric vaccines
- 6. Global Travel Vaccines Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Travel Vaccines Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Travel Vaccines Market Trends and Growth Opportunities
- 6.2.1 North America Travel Vaccines Market Outlook by Type
- 6.2.2 North America Travel Vaccines Market Outlook by Application
- 6.3 North America Travel Vaccines Market Outlook by Country
- 6.3.1 The US Travel Vaccines Market Outlook, 2021- 2032
- 6.3.2 Canada Travel Vaccines Market Outlook, 2021- 2032
- 6.3.3 Mexico Travel Vaccines Market Outlook, 2021- 2032
- 7. Europe Travel Vaccines Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Travel Vaccines Market Trends and Growth Opportunities
- 7.2.1 Europe Travel Vaccines Market Outlook by Type
- 7.2.2 Europe Travel Vaccines Market Outlook by Application
- 7.3 Europe Travel Vaccines Market Outlook by Country
- 7.3.2 Germany Travel Vaccines Market Outlook, 2021- 2032
- 7.3.3 France Travel Vaccines Market Outlook, 2021- 2032
- 7.3.4 The UK Travel Vaccines Market Outlook, 2021- 2032
- 7.3.5 Spain Travel Vaccines Market Outlook, 2021- 2032
- 7.3.6 Italy Travel Vaccines Market Outlook, 2021- 2032
- 7.3.7 Russia Travel Vaccines Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Travel Vaccines Market Outlook, 2021- 2032
- 8. Asia Pacific Travel Vaccines Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Travel Vaccines Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Travel Vaccines Market Outlook by Type
- 8.2.2 Asia Pacific Travel Vaccines Market Outlook by Application
- 8.3 Asia Pacific Travel Vaccines Market Outlook by Country
- 8.3.1 China Travel Vaccines Market Outlook, 2021- 2032
- 8.3.2 India Travel Vaccines Market Outlook, 2021- 2032
- 8.3.3 Japan Travel Vaccines Market Outlook, 2021- 2032
- 8.3.4 South Korea Travel Vaccines Market Outlook, 2021- 2032
- 8.3.5 Australia Travel Vaccines Market Outlook, 2021- 2032
- 8.3.6 South East Asia Travel Vaccines Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Travel Vaccines Market Outlook, 2021- 2032
- 9. South America Travel Vaccines Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Travel Vaccines Market Trends and Growth Opportunities
- 9.2.1 South America Travel Vaccines Market Outlook by Type
- 9.2.2 South America Travel Vaccines Market Outlook by Application
- 9.3 South America Travel Vaccines Market Outlook by Country
- 9.3.1 Brazil Travel Vaccines Market Outlook, 2021- 2032
- 9.3.2 Argentina Travel Vaccines Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Travel Vaccines Market Outlook, 2021- 2032
- 10. Middle East and Africa Travel Vaccines Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Travel Vaccines Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Travel Vaccines Market Outlook by Type
- 10.2.2 Middle East and Africa Travel Vaccines Market Outlook by Application
- 10.3 Middle East and Africa Travel Vaccines Market Outlook by Country
- 10.3.1 Saudi Arabia Travel Vaccines Market Outlook, 2021- 2032
- 10.3.2 The UAE Travel Vaccines Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Travel Vaccines Market Outlook, 2021- 2032
- 10.3.4 South Africa Travel Vaccines Market Outlook, 2021- 2032
- 10.3.5 Egypt Travel Vaccines Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Travel Vaccines Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Altimmune Inc
- AstraZeneca Plc
- Bavarian Nordic AS
- CSL Ltd
- Dynavax Technologies Corp
- Emergent BioSolutions Inc
- GlaxoSmithKline Plc
- KM Biologics Co. Ltd
- LG Chem Ltd
- Merck and Co. Inc
- Novartis AG
- Pfizer Inc
- Sanofi SA
- Serum Institute of India Pvt. Ltd
- Shenzhen Kangtai Biological Products Co. Ltd
- SK Chemicals Co. Ltd
- Takeda Pharmaceutical Co. Ltd
- Valneva SE
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
